Chinese PE Firm Shiyu Capital Leads Over $14M Series Pre-A Round In Biotech Start-Up

For Digital Subscribers Only

Biotheus, a Chinese start-up that specializes in the discovery and development of therapeutic biologics in the oncology disease space, announced on Wednesday that it has raised over RMB100 million (US$14.51 million) in a series pre-A round of financing led by Chinese healthcare-focused private equity firm Shiyu Capital.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in


RELATED NEWS



LEAVE A REPLY